STOCK TITAN

[Form 4] Diversified Healthcare Trust Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ:DHC), reported an equity award and resulting holdings. On 09/09/2025 Mr. Portnoy was awarded 81,775 common shares under the issuer's equity compensation plan, a transaction he reported on Form 4 with his signature dated 09/11/2025.

Following the award the filing shows 430,382.55 common shares listed as beneficially owned following the reported transaction and separately discloses 23,250,019 shares held by ABP Trust, of which Mr. Portnoy is sole trustee and which he may be deemed to beneficially own though he disclaims ownership except for his pecuniary interest.

Adam D. Portnoy, amministratore di Diversified Healthcare Trust (NASDAQ:DHC), ha riportato un premio azionario e le relative partecipazioni. Il 09/09/2025 a Mr. Portnoy è stato assegnato 81.775 azioni ordinarie secondo il piano di compensazione azionaria dell’emittente, una operazione che è stata riferita nel Form 4 con la sua firma datata 11/09/2025.

A seguito dell’assegnazione, la dichiarazione mostra 430.382,55 azioni ordinarie indicate come possedute in seguito all’operazione riportata e, separatamente, riporta 23.250.019 azioni detenute da ABP Trust, di cui il signor Portnoy è l’unico fiduciario e che potrebbe essere considerato possedere in modo beneficiario sebbene egli ne disconosca la proprietà, ad eccezione del suo interesse pecuniario.

Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ:DHC), informó sobre una asignación de acciones y las participaciones resultantes. El 09/09/2025 al señor Portnoy le fueron otorgadas 81.775 acciones ordinarias conforme al plan de compensación en acciones del emisor, una operación que reportó en el Formulario 4 con su firma fechada el 11/09/2025.

Tras la adjudicación, la declaración muestra 430.382,55 acciones ordinarias registradas como poseídas de manera beneficiosa tras la operación reportada y, por separado, divulga 23.250.019 acciones pertenecientes a ABP Trust, del cual Portnoy es el único fideicomisario y que podría considerarse poseer de forma beneficiosa, aunque él niega la propiedad salvo por su interés pecuniario.

Adam D. Portnoy는 Diversified Healthcare Trust(NASDAQ:DHC)의 이사로서 주식 보상 및 그에 따른 보유를 보고했습니다. 2025년 9월 9일 Portnoy 씨에게는 발행사의 주식 보상 계획에 따라 81,775주의 보통주가 부여되었으며, 이 거래는 서명일이 2025년 9월 11일로 기재된 Form 4에 보고되었습니다.

보상 이후 제출서에는 보고된 거래 이후에 유익하게 소유된 것으로 기재된 430,382.55주의 보통주가 기재되어 있으며, 별도로 ABP Trust가 보유한 23,250,019주의 주식이 기재되어 있습니다. Portnoy 씨는 이 신탁의 유일한 수탁자이며, 재정적 이해관계에 한해 유익하게 소유할 수 있다고 판단될 수 있지만 소유권은 부인합니다.

Adam D. Portnoy, directeur de Diversified Healthcare Trust (NASDAQ:DHC), a déclaré une attribution d’actions et les participations qui en résultent. Le 09/09/2025, M. Portnoy a reçu 81.775 actions ordinaires dans le cadre du plan de rémunération en actions de l’émetteur, une opération qu’il a déclarée sur le formulaire 4 avec sa signature datée du 11/09/2025.

Suite à l’attribution, le dépôt indique 430.382,55 actions ordinaires détenues à titre bénéficiaire après la transaction signalée et, séparément, divulgue 23.250.019 actions détenues par ABP Trust, dont M. Portnoy est l’unique fiduciaire et qui pourrait être réputé détenir de manière bénéficiaire bien qu’il nie la propriété, sauf pour son intérêt pécuniaire.

Adam D. Portnoy, Direktor von Diversified Healthcare Trust (NASDAQ:DHC), meldete eine Aktienzuweisung und die daraus resultierenden Beteiligungen. Am 09.09.2025 wurde Herrn Portnoy gemäß dem Emittenten-Aktienkompensationsplan 81.775 Stammaktien zugeteilt, eine Transaktion, die er im Formular 4 mit seiner Unterschrift datiert auf den 11.09.2025 gemeldet hat.

Nach der Zuteilung zeigt die Einreichung 430.382,55 Stammaktien, die als wirtschaftlich berechtigt nach der gemeldeten Transaktion gelten, und meldet außerdem separat 23.250.019 Aktien, die von ABP Trust gehalten werden, bei dem Portnoy der alleinige Treuhänder ist und die er möglicherweise als wirtschaftlich berechtigt besitzt, obwohl er das Eigentum bestreitet, außer seinem finanziellen Interesse.

آدم د. بورنوي، مدير Diversified Healthcare Trust (بورصة ناسداك:DHC)، قد أبلغ عن منحة أسهم وما يترتب عليها من ملكيات. في 09/09/2025 تم منح السيد بورنوي 81,775 سهماً عاديًا وفقًا لخطة تعويض الأسهم الخاصة بالشركة، وهي عملية أبلغ عنها في النموذج 4 بتوقيعه المؤرخ في 11/09/2025.

وبعد المنحة، يظهر الملف 430.382,55 سهماً عادياً مدرجاً كملك حق شخصي عقب المعاملة المطلوبة، ويفصح بشكل منفصل عن 23.250.019 سهماً مملوكة لـ ABP Trust، الذي يعد Portnoy أمين صندوقه الوحيد، ومن الممكن اعتبارها مملوكة مستفاداً رغم نفيه للملكية باستثناء مصلحته المالية.

Adam D. Portnoy,Diversified Healthcare Trust(纳斯达克股票代码:DHC)的董事,已报告一项股票授予及其产生的持股。2025年9月9日,Portnoy先生根据发行人的股票薪酬计划获得了< b>81,775股普通股,该交易已在Form 4中报告,签字日期为2025-09-11

授予后,备案显示作为对该交易的受益所有持有的普通股数量为430,382.55股,另外单独披露ABP Trust持有的23,250,019股,Portnoy先生为其唯一受托人,尽管他否认所有权,但在其财务利益范围内可能被视为受益所有者。

Positive
  • Insider alignment: Director received 81,775 shares under the issuer's equity compensation plan, aligning management incentives with shareholders
  • Transparent disclosure: Form 4 clearly reports the award date (09/09/2025) and the reporting signature (09/11/2025)
Negative
  • Concentrated trust holding disclosed: 23,250,019 shares are held by ABP Trust, potentially indicating concentrated influence though the filer disclaims beneficial ownership except for pecuniary interest
  • Limited context: Filing lacks percentages of outstanding shares and grant value, restricting assessment of materiality and economic impact

Insights

TL;DR Insider received a routine equity award of 81,775 shares; reported holdings and a large trust position are disclosed.

The Form 4 documents a standard equity compensation award rather than an open-market purchase or sale, which limits immediate market-signaling effects. The report shows 81,775 shares awarded on 09/09/2025 and a reported post-transaction beneficial ownership figure of 430,382.55 shares. For investors this is factual disclosure of insider remuneration and ownership but does not, by itself, quantify voting control, dilution impact, or value transfer because no exercise price, grant value, or percentage ownership of outstanding shares is provided in the filing.

TL;DR Filing confirms director compensation in equity and discloses a large trust holding that may affect governance perceptions.

The filing explicitly notes 23,250,019 shares held by ABP Trust where Mr. Portnoy is sole trustee and could be deemed a beneficial owner though he disclaims such ownership except for pecuniary interest. This is a material governance disclosure in that it identifies a concentrated share block tied to the reporting person; however, the Form 4 does not include any percentages, control statements, or voting arrangements, so the governance implications cannot be fully assessed from this document alone.

Adam D. Portnoy, amministratore di Diversified Healthcare Trust (NASDAQ:DHC), ha riportato un premio azionario e le relative partecipazioni. Il 09/09/2025 a Mr. Portnoy è stato assegnato 81.775 azioni ordinarie secondo il piano di compensazione azionaria dell’emittente, una operazione che è stata riferita nel Form 4 con la sua firma datata 11/09/2025.

A seguito dell’assegnazione, la dichiarazione mostra 430.382,55 azioni ordinarie indicate come possedute in seguito all’operazione riportata e, separatamente, riporta 23.250.019 azioni detenute da ABP Trust, di cui il signor Portnoy è l’unico fiduciario e che potrebbe essere considerato possedere in modo beneficiario sebbene egli ne disconosca la proprietà, ad eccezione del suo interesse pecuniario.

Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ:DHC), informó sobre una asignación de acciones y las participaciones resultantes. El 09/09/2025 al señor Portnoy le fueron otorgadas 81.775 acciones ordinarias conforme al plan de compensación en acciones del emisor, una operación que reportó en el Formulario 4 con su firma fechada el 11/09/2025.

Tras la adjudicación, la declaración muestra 430.382,55 acciones ordinarias registradas como poseídas de manera beneficiosa tras la operación reportada y, por separado, divulga 23.250.019 acciones pertenecientes a ABP Trust, del cual Portnoy es el único fideicomisario y que podría considerarse poseer de forma beneficiosa, aunque él niega la propiedad salvo por su interés pecuniario.

Adam D. Portnoy는 Diversified Healthcare Trust(NASDAQ:DHC)의 이사로서 주식 보상 및 그에 따른 보유를 보고했습니다. 2025년 9월 9일 Portnoy 씨에게는 발행사의 주식 보상 계획에 따라 81,775주의 보통주가 부여되었으며, 이 거래는 서명일이 2025년 9월 11일로 기재된 Form 4에 보고되었습니다.

보상 이후 제출서에는 보고된 거래 이후에 유익하게 소유된 것으로 기재된 430,382.55주의 보통주가 기재되어 있으며, 별도로 ABP Trust가 보유한 23,250,019주의 주식이 기재되어 있습니다. Portnoy 씨는 이 신탁의 유일한 수탁자이며, 재정적 이해관계에 한해 유익하게 소유할 수 있다고 판단될 수 있지만 소유권은 부인합니다.

Adam D. Portnoy, directeur de Diversified Healthcare Trust (NASDAQ:DHC), a déclaré une attribution d’actions et les participations qui en résultent. Le 09/09/2025, M. Portnoy a reçu 81.775 actions ordinaires dans le cadre du plan de rémunération en actions de l’émetteur, une opération qu’il a déclarée sur le formulaire 4 avec sa signature datée du 11/09/2025.

Suite à l’attribution, le dépôt indique 430.382,55 actions ordinaires détenues à titre bénéficiaire après la transaction signalée et, séparément, divulgue 23.250.019 actions détenues par ABP Trust, dont M. Portnoy est l’unique fiduciaire et qui pourrait être réputé détenir de manière bénéficiaire bien qu’il nie la propriété, sauf pour son intérêt pécuniaire.

Adam D. Portnoy, Direktor von Diversified Healthcare Trust (NASDAQ:DHC), meldete eine Aktienzuweisung und die daraus resultierenden Beteiligungen. Am 09.09.2025 wurde Herrn Portnoy gemäß dem Emittenten-Aktienkompensationsplan 81.775 Stammaktien zugeteilt, eine Transaktion, die er im Formular 4 mit seiner Unterschrift datiert auf den 11.09.2025 gemeldet hat.

Nach der Zuteilung zeigt die Einreichung 430.382,55 Stammaktien, die als wirtschaftlich berechtigt nach der gemeldeten Transaktion gelten, und meldet außerdem separat 23.250.019 Aktien, die von ABP Trust gehalten werden, bei dem Portnoy der alleinige Treuhänder ist und die er möglicherweise als wirtschaftlich berechtigt besitzt, obwohl er das Eigentum bestreitet, außer seinem finanziellen Interesse.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PORTNOY ADAM D.

(Last) (First) (Middle)
C/O THE RMR GROUP LLC
TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)
NEWTON MA 02458

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares of Beneficial Interest 09/09/2025 A 81,775 A (1) 430,382.55 D
Common Shares of Beneficial Interest 23,250,019 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.
2. These shares are held by ABP Trust; Mr. Portnoy, as the sole trustee, an officer and the controlling shareholder of ABP Trust, may be deemed to be a beneficial owner of these shares, but Mr. Portnoy disclaims such beneficial ownership except to the extent of his pecuniary interest therein.
/s/ Adam D. Portnoy 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Adam D. Portnoy report on Form 4 for DHC?

The Form 4 reports an equity award of 81,775 common shares to Adam D. Portnoy on 09/09/2025 under the issuer's equity compensation plan.

How many DHC shares does Adam D. Portnoy report as beneficially owned after the transaction?

The filing shows 430,382.55 common shares listed as beneficially owned following the reported transaction.

Does Adam D. Portnoy have any indirect holdings in DHC?

Yes. The Form 4 discloses 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee and may be deemed a beneficial owner, though he disclaims such ownership except to the extent of his pecuniary interest.

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 09/11/2025.

Was the reported transaction a purchase or sale?

The transaction code is A, indicating acquisition; the explanation states it was an award of shares pursuant to the issuer's equity compensation plan.

Does the Form 4 show exercise price or value for the award?

No. The filing lists the award quantity but does not provide an exercise price or monetary value for the granted shares.
Diversified Healthcare Tr

NASDAQ:DHC

DHC Rankings

DHC Latest News

DHC Latest SEC Filings

DHC Stock Data

1.05B
216.91M
10.23%
75.86%
2.07%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
NEWTON